Incorporating Differential Gene Expression Analysis with Predictive Biomarkers to Identify Novel Therapeutic Drugs for Fuchs Endothelial Corneal Dystrophy
Purpose. Based on the differential gene expression analysis for predictive biomarkers with RNA-Sequencing data from Fuchs endothelial corneal dystrophy (FECD) patients, we are aiming to evaluate the efficacy of Library of Integrated Network-based Cellular Signatures (LINCS) perturbagen prediction so...
Main Authors: | Huaming Wen, Ryan A. Gallo, Xiaosheng Huang, Jiamin Cai, Shaoyi Mei, Ammad Ahmad Farooqi, Jun Zhao, Wensi Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2021/5580595 |
Similar Items
-
Regenerative medicine in Fuchs' endothelial corneal dystrophy
by: Amy E Yuan, et al.
Published: (2021-01-01) -
The Genetic Basis of Fuchs Endothelial Corneal Dystrophy
by: Sepehr Feizi
Published: (2010-01-01) -
Fuchs endothelial corneal dystrophy: current perspectives
by: Vedana G, et al.
Published: (2016-02-01) -
Increased Corneal Endothelial Cell Migration in Fuchs Endothelial Corneal Dystrophy
by: Stephan Ong Tone, MDCM, PhD, et al.
Published: (2021-03-01) -
Cataract surgery in patients with Fuchs’ endothelial corneal dystrophy
by: Soujanya Kaup, et al.
Published: (2019-02-01)